Archives

Conference

Authors

Collaborators

Clear

Showing 4 of 4 Results

Actionable germline findings in endometrial cancer from a large multigene panel tested cohort

Oncology

Session:
#572

Date:
Monday, Jun 1, 2026 1:30pm – 4:30pm

Conference:
ASCO 2026

Authors:
Adela Rodriguez-Hernandez, Brittany L. Bychkovsky, Carolyn Horton, Huma Rana, Jessica D. St. Laurent, Judy E. Garber, Linda M. Polfus, Magan Trottier, Miki Horiguchi

Collaborators:

Dana Farber Cancer Institute
Harvard Medical School
Massachusetts General Hospital

Abstract Poster
Germline Pathogenic/Likely Pathogenic (P/LP) Variants in Epithelial Neuroendocrine Neoplasms: The Case for Universal Germline Genetic Testing

Oncology

Session:
#165

Date:
Saturday, May 30, 2026 9:00am – 12:00pm

Conference:
ASCO 2026

Authors:
Andrew Bellizzi, Brittany Sears, Cassidy Carraway, Chandrikha Chandrasekharan, Daniel M. Halperin, Jennifer A. Chan, Matthew Gao, Olatunji B. Alese, Po HEar, Renuka Iyer, Seth Jason Concors, Simron Singh, Udhayvir Singh Grewal

Collaborators:

Dana Farber Cancer Institute
Emory University
Harvard Medical School
Roswell Park Comprehensive Cancer Center
The University of Texas MD Anderson Cancer Center
University of Iowa
University of Toronto

Abstract
Pathogenic variants among female breast cancer patients with a subsequent cancer demonstrate preventable cancer burden

Oncology

Date:
Tuesday, Dec 7, 2021 12:00am – 12:00pm

Conference:
SABCS 2021

Authors:
Amal Yussuf, Carrie Horton, Holly Laduca, Judy E. Garber, Huma Rana, Brittany L. Bychkovsky, Min-Tzu Lo, Parichehr Hemyari

Collaborators:

Dana Farber Cancer Institute
Harvard Medical School

Poster Abstract
Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment.

Oncology

Session:
#71

Date:
Friday, May 29, 2020 12:00am – 12:00pm

Conference:
ASCO 2020

Authors:
Amal Yussuf, Holly Laduca, Judy E. Garber, Matthew B. Yurgelun, Hajime Uno, C. Sloane Furniss, Chinedu I. Ukaegbu, Miki Horiguchi, Anu B. Chittenden, Tara Fehlmann, Sapna Syngal

Collaborators:

Brigham and Women's Hospital
Dana Farber Cancer Institute
Harvard Medical School

Poster Abstract

Scientific Posters

Filter By

Actionable germline findings in endometrial cancer from a large multigene panel tested cohort

Germline Pathogenic/Likely Pathogenic (P/LP) Variants in Epithelial Neuroendocrine Neoplasms: The Case for Universal Germline Genetic Testing

Pathogenic variants among female breast cancer patients with a subsequent cancer demonstrate preventable cancer burden

Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment.

Patients

PROVIDERS

Solutions

Resources

Company

NOTICES

Scientific Posters

Filter By

Actionable germline findings in endometrial cancer from a large multigene panel tested cohort

Germline Pathogenic/Likely Pathogenic (P/LP) Variants in Epithelial Neuroendocrine Neoplasms: The Case for Universal Germline Genetic Testing

Pathogenic variants among female breast cancer patients with a subsequent cancer demonstrate preventable cancer burden

Development and validation of the PREMMplus clinical prediction model for multigene hereditary cancer risk assessment.

Get in Touch